Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000249764 | SCV000309671 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000725483 | SCV000337234 | uncertain significance | not provided | 2018-03-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082993 | SCV000649659 | benign | Qualitative or quantitative defects of dysferlin | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725483 | SCV000725425 | likely benign | not provided | 2020-03-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25312915) |
Illumina Laboratory Services, |
RCV001082993 | SCV001301080 | likely benign | Qualitative or quantitative defects of dysferlin | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Natera, |
RCV001272830 | SCV001455221 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-01-07 | no assertion criteria provided | clinical testing |